SCHEMBL27190077

SCHEMBL27190077

O=[N+]([O-])c1cc(Cl)c2c(C(F)(F)F)ccnc2c1O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 11/20 0.62
KDM4E B2RXH2 9/20 0.62
MEN1 O00255 9/20 0.62
KMT2A Q03164 9/20 0.62
TDP1 Q9NUW8 7/20 0.62
SMN1; SMN2 Q16637 7/20 0.62
HTT P42858 6/20 0.62
L3MBTL1 Q9Y468 5/20 0.62
LMNA P02545 5/20 0.62
PKM P14618 3/20 0.62
ALDH1A1 P00352 9/20 0.55
HSP90AA1 P07900 4/20 0.55
OPRK1 P41145 2/20 0.55
GAA P10253 3/20 0.53
CTSB P07858 3/20 0.53
IDO1 P14902 2/20 0.53
TDO2 P48775 2/20 0.53
POLB P06746 4/20 0.52
CASP6 P55212 3/20 0.52
RECQL P46063 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24716142 0.84 KDM4E (0.72) MAPTKDM4EMEN1KMT2ATDP1
SCHEMBL24715870 0.83 MAPT (0.67) MAPTKDM4EMEN1KMT2ATDP1
Hydrochloric Acid SCHEMBL29126360 0.83 MAPT (0.46) MAPTKDM4EMEN1KMT2ATDP1
Hydrochloric Acid SCHEMBL29126361 0.82 MAPT (0.45) MAPTKDM4EMEN1KMT2ATDP1
SCHEMBL27190043 0.79 KDM4E (0.45) MAPTKDM4EMEN1KMT2ATDP1
SCHEMBL30626599 0.77 ALDH1A1 (0.41) MAPTKDM4EMEN1KMT2ATDP1
SCHEMBL30626601 0.77 ALDH1A1 (0.41) MAPTKDM4EMEN1KMT2ATDP1
SCHEMBL27190080 0.77 MAPT (0.63) MAPTKDM4EMEN1KMT2ATDP1
SCHEMBL24715881 0.77 MEN1 (0.62) MAPTKDM4EMEN1KMT2ATDP1
SCHEMBL24715898 0.77 KDM4E (0.62) MAPTKDM4EMEN1KMT2ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240246916-A1 7-NITRO-8-HYDROXYQUINOLINE DERIVATIVES, PREPARATION METHOD THEREFORE AND MEDICAL USE THEREOF JIANGSU YAHONG MEDITECH CO., LTD. (CN) 2024-07-25 US disclosed
EP-4349815-A1 7-NITRO-8-HYDROXYQUINOLINE DERIVATIVE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF Jiangsu Yahong Meditech Co., Ltd. (CN) 2024-04-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240246916-A1 7-NITRO-8-HYDROXYQUINOLINE DERIVATIVES, PREPARATION METHOD THEREFORE AND MEDICAL USE THEREOF CYP3A7, UGT1A7, UGT2B7 MAPT 4416/4885KDM4E 2921/4885MEN1 970/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.